Ahmad, M. et al. 2020. Sofosbuvir plus Daclatasvir without Ribavirin for the Treatment of Chronic Hepatitis C in Patients with Decompensated Liver Disease: Response of sofosbuvir plus daclatasvir in decompensated cirrhosis. Journal of Fatima Jinnah Medical University. 14, 1 (Jul. 2020), 41–44. DOI:https://doi.org/10.37018/WOXS1774.